Breast Cancer Clinical Trial

Role of 3D Tomography in Breast Cancer

Summary

The primary aim of this pilot study is to define the role of dedicated cone beam breast computed tomography in breast cancer imaging. This research is a prelude of a more comprehensive clinical trial that may follow.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

All women, age 40 or older, who are scheduled for biopsy after classification as BI-RADS 4/5 and have had a screening or diagnostic full-field digital mammography (FFDM) exam are eligible to participate, except for exclusions noted below.
Able to provide informed consent.

Exclusion Criteria:

Males
Women less than 40 years old
Pregnant women
Lactating women
Woman who have had bilateral mastectomies
Women with physical limitations that may prohibit resting prone on the exam table, such as, but not limited to: frozen shoulder, recent heart surgery, pace maker
Women who are unable to tolerate study constraints, frail or unable to cooperate
Women with large breasts that cannot be accommodated within the field of view of the CT system

Women who have received radiation treatments to the thorax for malignant and nonmalignant conditions, such as (but not limited to)

Treatment for enlarged thymus gland as an infant
Irradiation for benign breast conditions, including breast inflammation after giving birth
Treatment for Hodgkin's disease
Women who have participated in a prior breast clinical trial that gave additional radiation dose, such as an additional mammogram.

Women who have received large numbers of diagnostic x-ray examinations for monitoring of disease such as (but not limited to)

Tuberculosis
Severe scoliosis

Study is for people with:

Breast Cancer

Estimated Enrollment:

150

Study ID:

NCT01090687

Recruitment Status:

Completed

Sponsor:

University of Rochester

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Rochester Medical Center, Highland Breast Imaging Center
Rochester New York, 14623, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

150

Study ID:

NCT01090687

Recruitment Status:

Completed

Sponsor:


University of Rochester

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider